Detalles de la búsqueda
1.
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy.
Blood
; 141(6): 609-619, 2023 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36351239
2.
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy.
Blood
; 139(14): 2173-2185, 2022 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34871373
3.
Coronavirus Disease 2019 mRNA Vaccination Appears Safe in Pediatric Patients With Hypersensitivity to Polyethylene Glycolated Escherichia coli L-asparaginase.
J Pediatr Hematol Oncol
; 46(2): e202-e204, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181327
4.
Bone marrow fibrosis is associated with non-response to CD19 CAR T-cell therapy in B-acute lymphoblastic leukemia.
Am J Hematol
; 98(12): 1888-1897, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37718626
5.
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001).
Haematologica
; 107(10): 2295-2303, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35112552
6.
Outcomes of children and young adults with T-cell acute lymphoblastic leukemia/lymphoma who present in critical status.
Pediatr Blood Cancer
; 69(4): e29457, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34997812
7.
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 69(11): e29937, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36083863
8.
Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients.
Antimicrob Agents Chemother
; 65(8): e0029021, 2021 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34031051
9.
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433.
Haematologica
; 106(1): 46-55, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32001530
10.
Nonviral RNA chimeric antigen receptor-modified T cells in patients with Hodgkin lymphoma.
Blood
; 132(10): 1022-1026, 2018 09 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29925499
11.
Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 67(5): e28112, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31944549
12.
Significance of CNS 2 cerebrospinal fluid status post-induction in pediatric and adolescent patients with acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 66(1): e27433, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30207055
13.
A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114).
Br J Haematol
; 177(3): 467-474, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28295182
14.
Chimeric antigen receptor T cells for sustained remissions in leukemia.
N Engl J Med
; 371(16): 1507-17, 2014 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-25317870
15.
Supportive care utilization and treatment toxicity in children with Down syndrome and acute lymphoid leukaemia at free-standing paediatric hospitals in the United States.
Br J Haematol
; 174(4): 591-9, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27161549
16.
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.
N Engl J Med
; 368(16): 1509-1518, 2013 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-23527958
17.
Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 63(11): 1943-8, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27437864
18.
Practical communication guidance to improve phase 1 informed consent conversations and decision-making in pediatric oncology.
Cancer
; 121(14): 2439-48, 2015 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25873253
19.
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.
Blood
; 121(26): 5154-7, 2013 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-23678006
20.
How we infuse blinatumomab.
Pediatr Blood Cancer
; 67(9): e28541, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32573958